Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Cantor Fitzgerald
Daiichi Sankyo
Dow
Teva
US Department of Justice
Accenture
Boehringer Ingelheim
US Army

Generated: June 24, 2018

DrugPatentWatch Database Preview

DIASTAT ACUDIAL Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Diastat Acudial, and what generic alternatives are available?

Diastat Acudial is a drug marketed by Valeant Pharms North and is included in one NDA.

The generic ingredient in DIASTAT ACUDIAL is diazepam. There are eight drug master file entries for this compound. Forty-nine suppliers are listed for this compound. Additional details are available on the diazepam profile page.
Summary for DIASTAT ACUDIAL
Drug patent expirations by year for DIASTAT ACUDIAL
Pharmacology for DIASTAT ACUDIAL
Ingredient-typeBenzodiazepines
Drug ClassBenzodiazepine

US Patents and Regulatory Information for DIASTAT ACUDIAL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Valeant Pharms North DIASTAT ACUDIAL diazepam GEL;RECTAL 020648-007 Sep 15, 2005 RX Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Valeant Pharms North DIASTAT ACUDIAL diazepam GEL;RECTAL 020648-006 Sep 15, 2005 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

Expired US Patents for DIASTAT ACUDIAL

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Valeant Pharms North DIASTAT ACUDIAL diazepam GEL;RECTAL 020648-007 Sep 15, 2005 ➤ Try a Free Trial ➤ Try a Free Trial
Valeant Pharms North DIASTAT ACUDIAL diazepam GEL;RECTAL 020648-006 Sep 15, 2005 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Paragraph IV (Patent) Challenges for DIASTAT ACUDIAL
Drugname Dosage Strength RLD Submissiondate
➤ Subscribe Rectal Gel 5 mg/mL, 2mL pre-filled syringe ➤ Subscribe 2008-12-23
➤ Subscribe Rectal Gel 5 mg/mL, 4mL pre-filled syringe ➤ Subscribe 2008-12-08

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Federal Trade Commission
Healthtrust
US Army
Moodys
AstraZeneca
Deloitte
Harvard Business School
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.